DOJ alleges that Arriva offered free upgrades of medically unnecessary glucometers to Medicare beneficiaries, and then billed Medicare for the equipment.
A court in San Diego has stated that part of the suit between Quidel and Beckman is void as a matter of law.
The company was encouraged by the clinical use of the existing handheld instrument in hospitals and soon plans to launch it with a broader menu, it said at AACC.
Researchers have established that two simple tests can determine whether a person meets guidelines to receive antiviral treatment.
Alere received clearance for the Afinion HbA1c Dx and for the Alere i Strep A 2, a rapid molecular test for the qualitative detection of Streptococcus pyogenes.
The company will pay the US $33.2 million to settle allegations that it caused hospitals to submit false claims to federal healthcare programs.
Sensitivity problems with rapid antigen tests are also helping the more accurate rapid molecular tests gain wider acceptance, manufacturers said.
Alere received FDA 510(k) clearances for four tests, including those for influenza A and B, strep A, and RNA-based respiratory syncytial virus.
Abbott's CEO said it is going to take a couple of years to get product launches and revenue growth that the company wants to see from its acquisition of Alere.
The three firms each had 510(k) clearances for multiple products from the FDA last month for marketing.